Estimating the effects of global patent protection in pharmaceuticals: A case study of quinolones in India
Estimating the effects of global patent protection in pharmaceuticals: A case study of quinolones in India
复制标题
DOI：
10.1257/aer.96.5.1477
复制
发表时间：
2006-12-01
影响因子：
10.7
通讯作者：
Jia, Panle
中科院分区：
文献类型：
--
作者：
Chaudhuri, Shubham;Goldberg, Pinelopi K.;Jia, Panle
在本文中，我们利用印度药品市场的系统性抗菌药物部分的氟喹诺酮类药物亚段的数据，实证调查了这一要求对发展中国家的福利影响。我们的研究结果表明，对TRIPS潜在的不利福利影响的担忧可能有一定的依据。我们估计，即使在存在价格管制的情况下，这一细分市场中所有国内产品的退出也会给印度经济带来巨大的福利损失。这种福利损失的绝大部分来自消费者福利的损失。
Under the Agreement on Trade-Related Intellectual Property Rights, the World Trade Organization members are required to enforce product patents for pharmaceuticals. In this paper we empirically investigate the welfare effects of this requirement on developing countries using data for the fuoroquinolones subsegment of the systemic anti-bacterials segment of the Indian pharmaceuticals market. Our results suggest that concerns about the potential adverse welfare effects of TRIPS may have some basis. We estimate that the withdrawal of all domestic products in this subsegment is associated with substantial welfare losses to the Indian economy, even in the presence of price regulation. The overwhelming portion of this welfare loss derives from the loss of consumer welfare.